{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+on+low+body+surface+area", "query": { "intervention": "Placebo on low body surface area" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 4, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T14:36:52.120Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05718921", "title": "A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis", "Psoriasis" ], "interventions": [ { "name": "YR001 Dose A on low body surface area", "type": "DRUG" }, { "name": "YR001 Dose A on middle body surface area", "type": "DRUG" }, { "name": "YR001 Dose A on high body surface area", "type": "DRUG" }, { "name": "YR001 Dose B on low body surface area", "type": "DRUG" }, { "name": "YR001 Dose B on middle body surface area", "type": "DRUG" }, { "name": "YR001 Dose B on high body surface area", "type": "DRUG" }, { "name": "Placebo on low body surface area", "type": "DRUG" }, { "name": "Placebo on middle body surface area", "type": "DRUG" }, { "name": "Placebo on high body surface area", "type": "DRUG" }, { "name": "YR001 Dose A on high body surface area twice daily", "type": "DRUG" }, { "name": "YR001 Dose B on high body surface area twice daily", "type": "DRUG" }, { "name": "Placebo on high body surface area twice daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hangzhou Yirui Pharmaceutical Technology Co., Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 54, "start_date": "2023-04-08", "completion_date": "2023-12-14", "has_results": false, "last_update_posted_date": "2024-01-24", "last_synced_at": "2026-09-26T14:36:52.120Z", "location_count": 1, "location_summary": "Encinitas, California", "locations": [ { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05718921" }, { "nct_id": "NCT02317640", "title": "TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Spinal Cord Injury" ], "interventions": [ { "name": "Testosterone Gel applied by a pump", "type": "DRUG" }, { "name": "Stand Training", "type": "OTHER" }, { "name": "Electrical Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DEVICE" ], "sponsor": "Kessler Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "58 Years", "sex": "MALE", "summary": "18 Years to 58 Years · Male only" }, "enrollment_count": 56, "start_date": "2017-03-15", "completion_date": "2022-10", "has_results": false, "last_update_posted_date": "2017-08-22", "last_synced_at": "2026-09-26T14:36:52.120Z", "location_count": 1, "location_summary": "West Orange, New Jersey", "locations": [ { "city": "West Orange", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02317640" }, { "nct_id": "NCT01843790", "title": "A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Disease" ], "interventions": [ { "name": "GCS-100", "type": "DRUG" }, { "name": "Placebo, Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "La Jolla Pharmaceutical Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2013-06", "completion_date": "2014-09", "has_results": false, "last_update_posted_date": "2015-09-01", "last_synced_at": "2026-09-26T14:36:52.120Z", "location_count": 4, "location_summary": "Tempe, Arizona • La Mesa, California • Denver, Colorado + 1 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "La Mesa", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01843790" }, { "nct_id": "NCT03751007", "title": "A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetes type1" ], "interventions": [ { "name": "AG019 - Low Dose", "type": "BIOLOGICAL" }, { "name": "Teplizumab", "type": "DRUG" }, { "name": "Placebo-AG019", "type": "DRUG" }, { "name": "Placebo-Teplizumab", "type": "DRUG" }, { "name": "AG019 - High Dose", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Precigen Actobio T1D, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 45, "start_date": "2018-10-24", "completion_date": "2021-10-13", "has_results": true, "last_update_posted_date": "2023-02-01", "last_synced_at": "2026-09-26T14:36:52.120Z", "location_count": 15, "location_summary": "Birmingham, Alabama • San Francisco, California • Ventura, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03751007" } ] }